Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

13.13
Delayed Data
As of Sep 23
 +0.19 / +1.47%
Today’s Change
6.17
Today|||52-Week Range
14.69
+5.97%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close12.94
Today’s open12.95
Day’s range12.61 - 13.30
Volume67,067
Average volume (3 months)103,414
Market cap$387.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)+12.61%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.72-3.98%
SPPISpectrum Pharmaceuti...-0.09-1.87%
PTCTPTC Therapeutics Inc+0.72+6.58%
HSKAHeska Corp-0.22-0.40%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Search for Jobs